Sort
39,280 grants matching “leukemia”
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
$423,312David R Plas · University Of Cincinnati · R01 · FY2021 · CA
Epigenetic drivers of cancer progression
$423,127Andrew P Feinberg · Johns Hopkins University · R01 · FY2019 · CA
The Role of MEIS1 in Hematopoiesis and Hematopoietic Transformation
$423,110Ashish Kumar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2016 · HL
Impact of aging and clonal hematopoiesis on epigenetic heterogeneity, evolvability, and leukemogenesis
$423,109Sheng Li · Jackson Laboratory · U01 · FY2021 · CA
The Molecular Actions of Imatinib Mesylate in GISTs
$423,095Andrew K Godwin · Fox Chase Cancer Center · R01 · FY2009 · CA
MECHANISMS OF MLL REARRANGEMENT IN LEUKEMIA
$423,091Andrew T. Vaughan · Loyola University Chicago · P01 · FY2007 · CA
Mechanistic biomarkers to enable Bcl2 inhibitor therapies for neuroblastoma
$423,029Michael D Hogarty · Children'S Hosp Of Philadelphia · R01 · FY2021 · CA
Biology of Alpha Particle Immunotherapy
$423,006David A Scheinberg · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Biology of Alpha Particle Immunotherapy
$423,006David A Scheinberg · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
The direct transcriptional regulation of cell cycle genes by cell identity factors during myeloid differentiation
$423,000Manu Manu · University Of North Dakota · R15 · FY2024 · HL
Nonsense-mediated mRNA decay and nonsense-mediated mRNA decay factors
$422,959Lynne E Maquat · University Of Rochester · R01 · FY2016 · GM
SOUTHWEST ONCOLOGY GROUP CA-13612
$422,947University Of Arizona · U10 · FY2001 · CA
Cellular and Molecular Regulation of Thrombopoiesis
$422,947Ramesh A Shivdasani · Dana-Farber Cancer Inst · R01 · FY2009 · HL
CALGB
$422,936Ohio State University · U10 · FY2000 · CA
Biology and Prognostic implications of Flt3 mutations in AML
$422,916Soheil Meshinchi · Fred Hutchinson Cancer Research Center · R01 · FY2008 · CA
Advancing CAR T cell therapy for solid tumors
$422,916Jalal Ahmed · Icahn School Of Medicine At Mount Sinai · DP5 · FY2021 · OD
Endocrine disrupter modulation of SXR in development and lymphomagenesis
$422,908Bruce Blumberg · University Of California-Irvine · R01 · FY2016 · ES
Role of PRC1 in RUNX1-ETO-mediated transcriptional control
$422,895Scott Hiebert · Vanderbilt University · R01 · FY2022 · CA
Phase I/II clinical trial of HDAC inhibition for GVHD prevention in children, adolescents, and young adults
$422,892Sung Won Choi · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
therapeutic Targeting of CD47 on Human Leukemia and Other Cancer Stem Cells
$422,881Irving Lerner Weissman · Stanford University · P01 · FY2010 · CA
North Shore CCOP
$422,875Vincent P Vinciguerra · Feinstein Institute For Medical Research · U10 · FY2008 · CA
Nonsense-mediated mRNA decay and nonsense-mediated mRNA decay factors
$422,845Lynne E Maquat · University Of Rochester · R01 · FY2015 · GM
Therapeutic targeting and biophysical characterization of CAR-mediated trogocytosis
$422,799Tim Luetkens · University Of Maryland Baltimore · R21 · FY2025 · CA
Molecular Cytogenetics Core
$422,797Anna Roschke · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Mechanisms of Apoptosis Dysregulation in AML
$422,758John C Reed · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA